Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Endocrinology

• Publication date

  2014-08-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2014-1034PMID 25137025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RET revisited: expanding the oncogenic portfolio

  2014cited by this paper
• Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.

  2013cited by this paper
• Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway

  2013cited by this paper
• Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells

  2012cited by this paper
• Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.

  2012cited by this paper
• Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas

  2012cited by this paper
• RET is a potential tumor suppressor gene in colorectal cancer

  2012cited by this paper
• A consensus on the diagnosis and treatment of acromegaly complications

  2012cited by this paper
• PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.

  2012cited by this paper
• The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint

  2012cited by this paper
• Resistance to somatostatin analogs in acromegaly.

  2011cited by this paper
• Kisspeptin regulates gonadotroph and somatotroph function in nonhuman primate pituitary via common and distinct signaling mechanisms.

  2011cited by this paper
• DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP).

  2011cited by this paper
• CEBPD suppresses prolactin expression and prolactinoma cell proliferation.

  2011cited by this paper
• Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

  2011cited by this paper
• No evidence of RET germline mutations in familial pituitary adenoma.

  2011cited by this paper
• Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome.

  2010cited by this paper
• Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary.

  2010cited by this paper
• A GRFa2/Prop1/Stem (GPS) Cell Niche in the Pituitary

  2009cited by this paper
• Pathology, Pathogenesis and Therapy of Growth Hormone (GH)-producing Pituitary Adenomas: Technical Advances in Histochemistry and Their Contribution

  2009cited by this paper
• Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

  2009cited by this paper
• Acromegaly pathogenesis and treatment.

  2009cited by this paper
• The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.

  2009cited by this paper
• Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion.

  2008cited by this paper
• GHRH proliferative action on somatotrophs is cell‐type specific and dependent on Pit‐1/GHF‐1 expression

  2008cited by this paper
• Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors.

  2008cited by this paper
• The dependence receptor Ret induces apoptosis in somatotrophs through a Pit‐1/p53 pathway, preventing tumor growth

  2007cited by this paper
• Dynamic Interactions between Pit-1 and C/EBPα in the Pituitary Cell Nucleus

  2006cited by this paper
• Dynamic interactions between Pit-1 and C/EBPalpha in the pituitary cell nucleus.

  2006cited by this paper
• Molecular mechanisms of pituitary differentiation and regulation: implications for hormone deficiencies and hormone resistance syndromes.

  2006cited by this paper
• Enhanced protein kinase B/Akt signalling in pituitary tumours.

  2005cited by this paper
• A Case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone — an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture

  2005cited by this paper
• Steroidogenic factor-1 and the gonadotrope-specific element enhance basal and pituitary adenylate cyclase-activating polypeptide-stimulated transcription of the human glycoprotein hormone alpha-subunit gene in gonadotropes.

  2003cited by this paper
• Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors.

  2002cited by this paper
• DEVELOPMENT OF A TRANSGENIC GREEN FLUORESCENT PROTEIN LINEAGE MARKER FOR STEROIDOGENIC FACTOR 1

  2002cited by this paper
• Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor.

  2001cited by this paper
• Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function.

  2001cited by this paper
• Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells*

  2000cited by this paper
• The RET proto‐oncogene induces apoptosis: a novel mechanism for Hirschsprung disease

  2000cited by this paper
• GDNF and RET-gene expression in anterior pituitary-cell types.

  2000cited by this paper
• GDNF and RET-Gene Expression in Anterior Pituitary-Cell Types.

  2000cited by this paper
• Pit-1 Binding Sites at the Somatotrope-specific DNase I Hypersensitive Sites I, II of the Human Growth Hormone Locus Control Region Are Essential for in Vivo hGH-N Gene Activation*

  1999cited by this paper
• Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.

  1999cited by this paper
• Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?

  1999cited by this paper
• Pit-1 Positive α-Subunit Positive Nonfunctioning Human Pituitary Adenomas: A Dediferentiated GH Cell Lineage?

  1999cited by this paper
• Early growth response protein 1 binds to the luteinizing hormone-beta promoter and mediates gonadotropin-releasing hormone-stimulated gene expression.

  1999cited by this paper
• Nuclear Receptor DAX-1 Recruits Nuclear Receptor Corepressor N-CoR to Steroidogenic Factor 1

  1998cited by this paper
• The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.

  1996cited by this paper
• RET proto-oncogene point mutations in sporadic neuroendocrine tumors.

  1996cited by this paper
• The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis.

  1994cited by this paper
• Expression of epithelial phenotype is enhanced by v-Ha-ras in rat endometrial cells immortalized by SV40 T antigen.

  1993cited by this paper
• Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth

  1992cited by this paper
• Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements

  1990cited by this paper
• Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues

  1990cited by this paper
• The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions.

  1990cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Relationship between Steroidogenic Factor 1 and DAX-1 Expression and in Vitro Gonadotropin Secretion in Human Pituitary Adenomas*

  year unknowncited by this paper

• RET signalling in the pituitary: a double-edged sword for differentiation, apoptosis and therapeutic strategies in acromegaly.

  2025cites this paper
• Steroidogenic Factor-1 regulates a core set of target genes to promote malignancy in adrenocortical carcinoma.

  2025cites this paper
• CRHR1 mediates the transcriptional expression of pituitary hormones and their receptors under hypoxia

  2022cites this paper
• RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

  2021cites this paper
• GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

  2020cites this paper
• Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly

  2019influential citation
• Molecular Mechanisms Governing Embryonic Differentiation of Pituitary Somatotropes.

  2018cites this paper
• Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis

  2017cites this paper
• MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells

  2017cites this paper
• Regulation of pituitary stem cells by epithelial to mesenchymal transition events and signaling pathways.

  2017cites this paper
• Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.

  2016cites this paper
• Pituitary Cell Turnover: From Adult Stem Cell Recruitment through Differentiation to Death

  2015cites this paper
• Proteomic and functional profiles of a follicle‐stimulating hormone positive human nonfunctional pituitary adenoma

  2015cites this paper
• The RET Receptor Family

  2015cites this paper